Упрощенная HTML-версия
РОЗДІЛ 8. ВЕДЕННЯ ВАГІТНИХ З ПАТОЛОГІЧНИМИ СТАНАМИ
163
20. Salomon LJ, Benattar C, Audibert F, Fernandez H, Duyme M, Taieb J, et al. Severe
preeclampsia is associated with high inhibin A levels and normal leptin levels at 7 to 13
weeks into pregnancy. Am J Obstet Gynecol 2003;189:1517-22.
21. Spencer K, Yu CK, Savvidou M, Papageorghiou AT, Nicolaides KH. Prediction of pre-
eclampsia by uterine artery Doppler ultrasonography and maternal serum pregnancy-
associated plasma protein-A, free beta-human chorionic gonadotropin, activin A and inhibin A
at 22 + 0 to 24 + 6 weeks’ gestation. Ultrasound Obstet Gynecol 2006;27:658-63.
22. Kurdi W, Campbell S, Aquilina J, England P, Harrington K. The role of color Doppler imaging of
the uterine arteries at 20 weeks’ gestation in stratifying antenatal care. Ultrasound Obstet
Gynecol 1998;12:339-45.
23. Chappell LC, Seed PT, Briley A, Kelly FJ, Hunt BJ, Charnock-Jones DS, et al. A longitudinal
study of biochemical variables in women at risk of preeclampsia. Am J Obstet Gynecol
2002;187:127-36.
24. Krauss T, Pauer HU, Augustin HG. Prospective analysis of placenta growth factor (PlGF)
concentrations in the plasma of women with normal pregnancy and pregnancies complicated
by preeclampsia. Hypertens Pregnancy 2004;23:101-11.
25. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, et al. Circulating angiogenic
factors and the risk of preeclampsia. N Engl J Med 2004;350:672-83.
26. Halligan A, Bonnar J, Sheppard B, Darling M, Walshe J. Haemostatic, fibrinolytic and
endothelial variables in normal pregnancies and pre-eclampsia. Br J Obstet Gynaecol
1994;101:488-92.
27. Caron C, Goudemand J, Marey A, Beague D, Ducroux G, Drouvin F. Are haemostatic and
fibrinolytic parameters predictors of preeclampsia in pregnancy-associated hypertension?
Thromb Haemost 1991;66:410-4.
28. Yu CK, Smith GC, Papageorghiou AT, Cacho AM, Nicolaides KH. An integrated model for the
prediction of preeclampsia using maternal factors and uterine artery Doppler velocimetry in
unselected low-risk women. Am J Obstet Gynecol 2005;193:429-36.
29. Liston R, Sawchuck D, Young D. Fetal health surveillance: antepartum and intrapartum
consensus guideline. Society of Obstetrics and Gynaecologists of Canada; British Columbia
Perinatal Health Program. J Obstet Gynaecol Can. 2007 Sep;29(9 Suppl 4):S3-56.
30. von Dadelszen P, Magee LA, Lee SK, Stewart SD, Simone C, Koren G, et al. Activated protein
C in normal human pregnancy and pregnancies complicated by severe preeclampsia: A
therapeutic opportunity? Crit Care Med 2002;30:1883-92
31. Abalos E, Duley L, Steyn DW, Henderson-Smart DJ. Antihypertensive drug therapy for mild to
moderate hypertension during pregnancy. Cochrane Database Syst Rev 2001;CD002252.
32. Magee LA, von Dadelszen P, Chan S, Gafni A, Gruslin A, Helewa ME, et al. The CHIPS Pilot
Trial (Control of Hypertension In Pregnancy Study). J Obstet Gynaecol Can 2006;28:416.
33. Magee LA, von Dadelszen P, Chan S, Gafni A, Gruslin A, Helewa ME, et al. The CHIPS Pilot
Trial (Control of Hypertension In Pregnancy Study). Hypertens Pregnancy 2006;25:21.
34. Duley L, Henderson-Smart DJ, Knight M, King JF. Antiplatelet agents for preventing pre-
eclampsia and its complications. Cochrane Database Syst Rev 2004;CD004659.
35. Keim SA, Klebanoff MA. Aspirin use and miscarriage risk. Epidemiology 2006;17:435-9.
36. Ruano R, Fontes RS, Zugaib M. Prevention of preeclampsia with low-dose aspirin —a
systematic review and meta-analysis of the main randomized controlled trials. Clinics
2005;60:407-14.
37. Ebrashy A, Ibrahim M, Marzook A, Yousef D. Usefulness of aspirin therapy in high-risk
pregnant women with abnormal uterine artery Doppler ultrasound at 14-16 weeks
pregnancy: randomized controlled clinical trial. Croat Med J 2005;46:826-31.
38. Caron N, Rivard GE, Rey E. Platelet function analyser (PFA-100) in pregnant women under
low dose aspirin (AAS). Thromb Res 2005;115:114.
39. Leonhardt A, Bernert S, Watzer B, Schmitz-Ziegler G, Seyberth HW. Low-dose aspirin in
pregnancy: maternal and neonatal aspirin concentrations and neonatal prostanoid
formation. Pediatrics 2003;111:e77-e81.
40. Hermida RC, Ayala DE, Iglesias M. Administration time-dependent influence of aspirin on
blood pressure in pregnant women. Hypertension 2003;41:651-6.
41. de Swiet M, Redman CW. Aspirin, extradural anaesthesia and the MRC Collaborative Low-
dose Aspirin Study in Pregnancy (CLASP). Br J Anaesth 1992;69:109-10.